Media Headlines

KSHB: Saint Luke's Hospice and Will Shields partner on grief camp for kids who have lost loved ones
Saint Luke's Hospice and Will Shields' Will to Succeed Foundation and 68 Fitness & Sports Training have joined forces to host WILLPower: Healing in Motion, a one-day camp for kids, ages 6 to 18, who are grieving the death of a loved one.
Healthline: Hot Flashes Are More Than Annoying — They Could Signal Heart Disease
It was thought that a woman experiencing hot flashes was about to enter midlife, but now a new study suggests it could be something else - heart disease.
FOX4: Metro woman finds priceless relief from chronic migraines through Botox injections
Angela Florez was dealing with more than a dozen painful migraines a month until she tried a different treatment option. FOX4 talked to Dr. Jennifer Elliott about how Botox injections can be used for pain relief.
FOX4: Chiefs superfan celebrates anniversary of surviving near-fatal heart attack
After surviving a serious heart attack, Dan Boos came to Saint Luke's to show appreciation for his doctors and care team for saving his life.
Media Coverage: Quarter of a million people expected to attend 2019 Plaza Art Fair
Over 250,000 people are expected to attend the Plaza Art Fair as Saint Luke's celebrates five years as the presenting sponsor.
KC LIVE: Saint Luke's celebrating five years as Plaza Art Fair presenting sponsor
Saint Luke's is celebrating five years as the presenting sponsor of the Plaza Art Fair and more than 135 years of serving the health needs of Kansas City.
KMBC: Doctors remove blood clot in 19-year-old's lung with advanced FlowTriever procedure
After feeling chest pain, Gina Cusimano's suspected asthma turned out to be something much more serious. KMBC talked to Dr. Cho about how he removed a blood clot in her lung with the FlowTriever device.
TCTMD: DEFINE-HF: Dapagliflozin Improves Function and Quality of Life, but Not Biomarkers, in HFrEF
A new study championed by Saint Luke's, called DEFINE-HF, was recently presented at the Heart Failure Society of America annual meeting. tctMD breaks down this groundbreaking study of the new treatment option with study chair Mikhail Kosiborod, MD.